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Twenty-five years of experience with out-center hemodialysis. patients in hospital centers was restricted, and home he-
Background. Out-center hemodialysis (HD) offers patients modialysis (H-HD) rapidly developed. Thereafter, the
a better quality of life, a greater independence, and a better number of facilities increased, and the enthusiasm forrehabilitation opportunity. A lower mortality than with other
H-HD treatment diminished despite reports of a lowermodalities of dialysis has been reported. In addition, in France
mortality rate than in full-care center HD or peritonealthe charges paid depend on the modality of dialysis, out-center
HD being the less expensive, and savings are also accomplished dialysis (PD) treatment [1–3], and despite the better
through fewer patient transports, which are additionally reim- quality of life and the greater independence and rehabili-
bursed. We present a 25-year experience of out-center HD. tation opportunity offered by H-HD to end-stage renalMethods. We retrospectively studied the clinical records of
disease (ESRD) patients [4, 5]. Since 1984, self-care HD471 patients treated between 1974 and 1997 in a single nonprofit
(SC-HD) units were developed as another alternative oforganization operating regional home HD (H-HD) and facili-
ties for self-care HD (SC-HD). Survival results were analyzed the out-center HD, answering requirements of autono-
according to: (a) causes of end-stage renal disease, (b) age at mous patients who did not have the possibility to be
the start of HD, (c) period of start of HD, (d) modality of HD treated at home. The price of reimbursement of HD in(H-HD, SC-HD), and (e) a subgroup of 174 patients defined
France depends on the modality of treatment, with out-at risk because they were contraindicated for transplantation.
center HD (H-HD and SC-HD) being less expensive. TheResults. The mean age at the start of HD increased from
31.2 6 9.7 (mean 6 sd) years in 1974 to 52.6 6 13.5 years in actual health policy requires a better control of expenses
1997. Causes of the end of treatment were: (a) transplantation while keeping the best quality of health care. Nowadays,
(63%), (b) transfer (20%), and (c) death (17%). The overall it is important to clearly define at the start of dialysis
survival was 90% at 5 years, 77% at 10 years, 62% at 15 years,
which modality is most suitable and which could offerand 45% at 20 years, and, for the group at risk, 78%, 62%,
the individual patient a better chance of survival. In46%, and 31%, respectively. Cox proportional hazard analyses
showed that risk factors were older age, diabetes, and renal ESRD chronic treatment, an analysis of survival is the
vascular diseases. best method to estimate the long-term results.
Conclusion. If adequate choice is given, out-center HD of- The “Association pour l’Utilisation du Rein Artificiel
fers a reliable and safe modality of dialysis with better survival
a` Lyon” (A.U.R.A.L.) was created in 1974 to developresults than survival in full-care in-center HD. In addition, out-
out-center dialysis treatment in the Rhoˆne-Alps area (acenter HD ensures a striking financial benefit as compared
total population of 5.35 million inhabitants) situated inwith the higher costs if the same patients were treated with
full-care in-center HD. These modalities should be encouraged the southeast section of France. In this article, the two
for all HD patients who are able to be treated by out-center out-center HD modalities that were used are described:
modalities. H-HD and SC-HD. Our survival results are analyzed,
and found to be better than the overall survival observed
in center facilities in Europe [6, 7], Japan [8] and the
The development of dialysis modalities is dependent United States [9]. Finally, the financial aspects are dis-
on economic resources. At the start of chronic treatment cussed, with a comparison between the costs of out-
by dialysis in the 1960s, the capacity to receive all dialysis center HD and the costs in hospital centers in France.
Key words: dialysis modalities, home hemodialysis, self-care hemodial- METHODSysis, end-stage renal disease, renal replacement therapy.
Patients
Received for publication January 25, 1999
From January 1974 to December 1997, 654 patientsand in revised form June 30, 1999
Accepted for publication July 19, 1999 were admitted in our training center, 102 patients for
PD and 552 for out-center HD (H-HD or SC-HD). Be- 1999 by the International Society of Nephrology
2269
Arkouche et al: Survival in out-center HD2270
fore 1991, patients were treated by peritoneal dialysis Acetate buffer has been replaced by bicarbonate since
1990, and the use of unmodified cellulosic membrane(PD) in our units solely when HD was contraindicated.
Therefore, to avoid a bias in patient selection, we did not was stopped in 1988, replaced by modified cellulosic or
synthetic high-flux membrane. Reuse was not per-include patients treated by PD in this analysis. Moreover,
only new HD patients who were treated at least three formed. Erythropoietin was introduced in 1992.
months in our facilities were included. To avoid interfer-
Calculationsences of other modalities of ESRD treatment and to
specifically study the quality of HD treatment offered Our data registry includes age, gender, causes of
ESRD, presence of diabetes, modalities of dialysis, datein A.U.R.A.L., patients coming from other centers or
other modalities of dialysis or who returned to dialysis of the start of dialysis in A.U.R.A.L., date of the end of
dialysis in A.U.R.A.L., outcome of patients, and theafter transplantation failure were excluded. Therefore,
the survival analyses concerned 471 patients [mean age causes of death.
The survival study started at the entry in our trainingat the start of HD 43.5 6 14.2 years (ranges 18.0 to 78.0),
132 females and 339 males] who were treated in out- center and stopped at the end of this treatment in our
structures either by death, transplantation, or transfer,center HD modalities (H-HD, SC-HD) and who started
chronic HD in our facilities. and was stopped on December 31, 1997, for patients re-
maining treated in our facilities. The annual gross mortal-
Definition of dialysis modalities ity rate (GMR) was calculated as the number of deaths
divided by half the number of patients alive on January 1In France, the out-center HD is accomplished either
by H-HD or SC-HD, the selection being done at the plus half the number alive on December 31 of each year.
Survival curves were analyzed for overall patientsstart of the training.
For H-HD, patients and assistants (often the spouses) treated in A.U.R.A.L. Results were also analyzed ac-
cording to the causes of ESRD. Patients were catego-were trained for two to four months and then were set-
tled at home. Once at home, the patients made quarterly rized according to the HD start age: 18 to 34 years (136
patients), 35 to 44 years (107 patients), 45 to 54 yearsmedical visits to the training center.
The SC-HD was applied in facilities out of the full- (111 patients), 55 to 64 years (87 patients), and $65
years (30 patients) with a comparison between thesecare center HD. Patients were trained during two to four
months until reaching autonomy and were then settled groups. Patients were also categorized in chronological
cohorts according to the period of the start of HD, andin self-care facilities. In our structures, the organization
of the SC-HD gave the possibility of patients to keep survival was analyzed according to the following cohorts:
period 1974 to 1980 (78 patients), period 1981 to 1985their autonomy, have a personal machine for each pa-
tient that was not used by the other patients, and to (108 patients), period 1986 to 1990 (121 patients), and
period 1991 to 1997 (164 patients). The survival datachoose the best schedule for the HD session that was
adapted to their activities, either in the morning or in the were also analyzed according to the modalities of dial-
ysis, that is, H-HD and SC-HD.evening. A nurse was present during all of the sessions in
order to help patients if necessary. The physician visited To analyze the survival results without the power im-
pact of withdrawal by transplantation or by transfer tothese units monthly, and the patients had quarterly medi-
cal visits in the training center. other facilities, we selected a group of 174 patients, age
49.5 6 14.2 years, who were continuously followed inThe reliability of the machines and the water treat-
ment were inspected by technicians at regular intervals our facilities, including only patients still dialyzed in
A.U.R.A.L. and those deceased. This group of 174 pa-both at home and in the self-care facilities. Patients were
able call the training center and discuss any problem tients could be considered at risk because they were not
accepted for transplantation, especially because of theirthat appeared during the dialysis session with a nurse,
a physician, or a technician. If the problem seemed to old age and/or medical contraindication.
Results of survival were then compared with survivalbe important, the session could be performed in the
training center. Availability of the medical and technical in center HD reported in Europe [6, 7], Japan [8], and
the United States [9].teams was very important in the success of the treatment
and helped to ensure good results.
Statistics
Dialysis policy Data were managed on a “Power Macintosh.” Data-
base software and statistical calculations including sur-The frequency of dialysis was three times per week,
and the session length was four to six hours, with a blood vival curves were done using Statview F-4.5 software
(Abacus Concepts Incorporated, Berkeley, CA, USA).flow between 250 and 350 ml/min and a dialyzate flow
at 500 ml/min. Generally, blood access was an arteriove- Results were presented as mean 6 sd. Analysis of vari-
ance was used to compare the characteristics betweennous fistula and exceptionally an arteriovenous graft.
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Table 1. Characteristics of new patients and gross mortality rate (GMR)
Year New pts Diabetic Sex M/F H-HD/SC-HD Age at start Death Transplant Transfer GMR
1974 9 0 9/0 9/0 31.269.7 0 0 0 0.000
1975 8 0 6/2 8/0 32.368.2 0 1 0 0.000
1976 14 1 11/3 14/0 37.1610.3 0 2 0 0.000
1977 15 2 11/4 15/0 37.469.8 3 2 1 0.092
1978 10 0 9/1 10/0 38.4612.0 2 1 4 0.053
1979 10 2 7/3 10/0 42.4610.0 0 5 5 0.000
1980 12 0 9/3 12/0 38.7613.5 0 2 1 0.000
1981 14 1 10/4 14/0 37.6613.1 1 2 5 0.019
1982 20 0 13/7 20/0 39.7610.6 2 10 5 0.035
1983 23 1 20/3 23/0 43.2612.9 2 4 2 0.031
1984 33 1 22/11 12/21 41.9616.6 3 5 4 0.036
1985 18 0 15/3 9/9 38.2615.2 1 6 2 0.010
1986 29 0 16/13 15/14 44.6613.4 2 10 1 0.018
1987 22 0 13/9 11/11 47.6611.7 1 14 4 0.008
1988 25 3 20/5 10/15 46.9613.3 2 15 2 0.016
1989 25 0 22/3 7/18 42.6614.3 4 22 2 0.032
1990 20 0 15/5 6/14 47.6617.4 4 19 7 0.034
1991 20 2 13/7 4/16 39.9617.0 0 15 5 0.000
1992 19 0 12/7 3/16 49.6612.0 3 15 3 0.027
1993 24 1 14/10 3/21 43.3613.7 2 11 3 0.017
1994 27 1 21/6 4/23 44.7615.9 0 19 4 0.000
1995 25 1 19/6 5/20 46.1613.7 10 15 3 0.081
1996 29 4 19/10 5/24 49.4614.1 6 15 5 0.048
1997 20 3 13/7 2/18 52.6613.5 12 14 5 0.100
Total 471 23 339/132 60 224 73
The number of new patients (pts), the number of diabetics, the sex ratio (male/female), the ratio of home hemodialysis (H-HD)/self-care hemodialysis (SC-HD),
the age at the start of hemodialysis treatment, the causes of the end of the treatment in A.U.R.A.L. (death, transplantation, or transfer), and the gross mortality
rate (GMR).
the groups according to the outcome of patients. Survival 1997. Diabetes was the cause of ESRD in only 5% of
the cases, renal vascular diseases in 12%, and chroniccurves were drawn using the Kaplan–Meier method, and
a comparison between survival curves was analyzed us- glomerulonephritis (CGN) in 45%. The overall other
causes, which included interstitial nephritis, polycysticing log-rank test. Cox proportional hazard analysis was
performed to determine the relative risk (hazard ratio) kidney disease, and other known causes, accounted for
34%, and the unknown causes accounted for 4%. Forty-of each studied covariate: sex (female as reference),
nine percent of the patients were treated at home andcauses of ESRD (CGN as reference), age at the start of
51% in self-care facilities. Since 1984, H-HD decreasedHD (group of age #34 years as reference), period of the
dramatically, and on 1997, it represented only 10% ofstart of HD (period 1986 to 1990 as reference), and
the new patients settled for out-center HD.modality of dialysis (SC-HD as reference).
The outcome of the patients in our facilities was dis-
tributed between transplantation (63%), transfer (to
RESULTS center structures or to other regions, 20%), and death
A 1994 report showed that in the Rhoˆne-Alps area, (17%). The waiting time in dialysis before transplanta-
3213 ESRD patients were treated on December 31, 1993, tion was 3.0 6 2.8 years. Causes of death were cardiovas-
which was equivalent to 573 per million population: 1708 cular diseases (50%), infections (12%), cancer (10%),
patients were undergoing maintenance dialysis (319 per cerebrovascular diseases (4%), and miscellaneous (24%).
million population), and 1505 patients had a functioning The GMR was 2.74 6 2.94% (ranges 0 to 10%; median
transplant [10]. During the year 1993, 406 new patients 1.85%). However, the GMR increased progressively since
started dialysis (75.8 per million population). Dialysis 1995 and reached 10% in 1997. The cumulative survival
patients were treated by PD (12%), SC-HD (16.6%), of the overall patients was 90% at 5 years, 77% at 10
and H-HD (7%) and by full-care in-center HD (64.4%). years, 62% at 15 years, and 45% at 20 years (Table 2).
Table 1 shows the characteristics of incident patients Figure 1 shows the survival curves according to the
from 1974 to 1997, the distribution between H-HD and ESRD causes. Significant differences were observed be-
SC-HD, the causes of the end of the treatment in our tween groups (P , 0.0001), with diabetes and renal vas-
center (death, transplantation, transfer), and the GMR. cular diseases having the worse results. Figure 2 shows
The mean age at the start of HD treatment increased curves according to the age at the start of HD with
significant differences (P , 0.0001). However, no sig-from 31.2 6 9.7 years in 1974 to 52.6 6 13.5 years in
Arkouche et al: Survival in out-center HD2272
Table 2. Survival according to the age at the start of hemodialysis
Age years
#34 35–44 45–54 55–64 $65 Total
Overall patients
N patients (136) (107) (111) (87) (30) (471)
Survival
5 years 0.98 0.93 0.85 0.83 0.72 0.90
10 years 0.89 0.83 0.82 0.64 0.49 0.77
15 years 0.89 0.75 0.59 0.44 — 0.62
20 years 0.75 0.50 — — — 0.45
Continuously followed group
N patients (28) (28) (46) (47) (25) (174)
Survival
5 years 0.92 0.73 0.71 0.75 0.81 0.78
10 years 0.79 0.50 0.67 0.55 0.51 0.62
15 years 0.79 0.41 0.46 0.36 — 0.46
20 years 0.65 0.29 0.33 — — 0.31
Results of survival at 5, 10, 15 and 20 years are shown for the group of overall patients and the group of patients continuously followed in our facilities. The
number of patients enclosed in the survival analyses are in parentheses.
Fig. 1. Survival curves drawn as Kaplan-Meier method in groups ac- Fig. 2. Survival curves drawn as Kaplan-Meier method in groups ac-
cording to causes of ESRD. Diabetes and vascular causes have the cording to the age at the start of hemodialysis, with significant differ-
poorer prognosis. ences.
eases), was 78% at 5 years, 62% at 10 years, 46% at 15
nificant differences were found according to the periods years, and 31% at 20 years (Table 2).
of the start of HD between 1974 and 1997 (data not The results of Cox hazard analyses are summarized
shown). Survival was comparable between H-HD and in Table 3 for the group of overall patients. The results
SC-HD (data not shown). The cumulative survival for were influenced by age. There was no marked sex differ-
the subgroup of 174 patients continuously followed in ence in survival. Diabetes and renal vascular diseases
A.U.R.A.L., who were neither considered for trans- had the significantly worse prognosis. The period of the
plantation nor transferred, and including 24% of high start of HD and the modality of HD did not influence
the prognosis.risk etiologies (9% diabetes and 15% renal vascular dis-
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Table 3. Results of Cox hazard analyses
Covariates N patients % Pts Hazard risk 95% CI P value
Sex
Female 132 28 1
Male 339 72 1.398 0.717–2.727 0.326
Cause of ESRD
CGN 212 45 1
Other 160 34 1.205 0.619–2.345 0.5838
Unknown 20 4 1.364 0.289–6.432 0.6948
Vascular 56 12 2.558 1.187–5.513 0.0165
Diabetes 23 5 7.009 2.801–17.542 ,0.0001
Age at start of HD
#34 years 136 29 1
35–44 years 107 23 2.884 1.121–7.418 0.0280
45–54 years 111 24 2.744 1.037–7.259 0.0420
55–64 years 87 18 5.462 2.029–14.707 0.0008
$65 years 30 6 7.715 2.435–24.437 0.0005
Period of start of HD
1974–1980 78 16 1.040 0.395–2.740 0.9365
1981–1985 108 23 1.325 0.593–2.961 0.4927
1986–1990 121 26 1
1991–1997 164 35 1.700 0.653–4.424 0.2770
Modality of dialysis
SC-HD 240 51 1
H-HD 231 49 1.535 0.718–3.282 0.2694
A total group of 471 patients is shown. Abbreviations are: 95% CI, confidence intervals; Pts, patients; ESRD, end-stage renal disease; CGN, chronic glomerulonephri-
tis; HD, hemodialysis; SC-HD, self-care hemodialysis; H-HD, home hemodialysis. Significantly different from reference, P , 0.05.
DISCUSSION work. Nevertheless, 49% of overall patients were treated
in H-HD and 51% in self-care facilities, and the survivalFew data are yet available on survival in specific out-
results were comparable in these two groups, suggestingcenter HD populations. H-HD was estimated to be only
that the choice of the method depends rather on personal0.1% of the overall dialyzed population in Japan [11]
preference than on the medical condition of the patients.and 1% of the overall dialyzed population in the United
This study showed excellent survival results. The meanStates [1].
age at the start of HD increased progressively from 31.2 6The annual report of the European registry (EDTA)
9.7 years in 1974 to 52.6 6 13.5 years in 1997, and the[12] showed that on December 31, 1995, 33,713 patients
GMR also increased progressively, reaching 10% inwere treated in France for ESRD (580 per million popu-
1997. This more pronounced GMR could be explainedlation), with 61.7% of patients treated by dialysis. In the
by the older age of patients currently dialyzed and theRhoˆne-Alpes area [10], the number of ESRD patients
accumulation of years of dialysis. Diabetes and renaltreated on December 31, 1993, is similar to the French
vascular diseases had significant differences of survivalnational prevalence. However, only 53% were undergoing
when compared with CGN and with the other causes of
maintenance dialysis, and 23.6% of the dialyzed population
ESRD, with worse results being observed for diabetic
were undergoing an out-center HD procedure (H-HD, patients. Death was registered in 17% of the overall
SC-HD). Four nonprofit organizations deliver PD and outcome. Cardiovascular diseases accounted for 50% of
out-center HD in the Rhoˆne-Alps area, A.U.R.A.L. be- the causes of the fatal evolution, which was similar to
ing the oldest, with 25 years of experience in the specific other published studies [8, 13]. Infections were the causes
out-center dialysis treatment. of death in only 12% of the cases, in part because the
Since 1984, the year of the opening of the first self- absence of the nosocomial infection risk, which is more
care facility in our region, the home-HD dramatically prevalent in hospital centers. In a United States Renal
decreased, and presently only 10% of the new out-center Data System report, infection accounts for almost a quar-
HD patients are choosing the H-HD. Indeed, the SC-HD ter of all deaths in the 20- to 44-year age group, 17%
in our structures is presented as a real alternative of and 14% of deaths in the 45- to 64-year and 65-year and
H-HD, essentially to autonomous patients who do not older age groups, respectively [9].
have the possibility of being treated at home. Each pa- In this study, transplantation represented 63% of the
tient has his personal machine that is not used by the overall outcome, confirming our policy of encouraging
other patients. In addition, patients have the possibility transplantation when it is possible. The high rate of trans-
of choosing a timing of the HD session that is adapted plantation associated with the transfer of patients to other
locations complicated data collection and analyses. Toto their activities, in the morning or in the evening after
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analyze the survival results without the power impact of HD depends on the modality of treatment, with the out-
withdrawal by transplantation or by transfer, we selected center HD (H-HD, SC-HD) being the less reimbursed
a group of 174 patients who were continuously followed [16]. H-HD and SC-HD are 50% less expensive than
in A.U.R.A.L. These patients did not have the possibility full-care in center HD [16, 17]. An analysis of the annual
of being transplanted because of their old age and/or costs of dialysis treatments performed in France in 1994
because of medical contraindication. Although this group estimated the expenditure per patient at $80,000 for the
represented patients at risk, their cumulative survival full-care in-center HD, $50,000 for the SC-HD, $42,000
was also satisfactory. for the H-HD, and $42,000 for continuous ambulatory
The comparison of survival results between different PD (all in U.S. dollars) [16]. In fact, no staff is needed
centers should be used with caution because there are for H-HD, and fewer staff are needed in the self-care
regional differences of life expectancy in the general facilities than in full-care center HD. Moreover, the geo-
population. Varieties in dialysis procedures and comor- graphic distribution of the centers in France is restricted
bid factors should also be taken into account. Finally, to the great urban centers, and patients sometimes travel
the withdrawal rate for kidney transplantation fluctu- for long distances between home and centers. In contrast,
ated. Hull and Parker reported that countries with high H-HD spares transport costs, and many self-care facili-
rates of transplantation will probably have the highest ties were installed in the large and also in the small cities
dialysis-related mortality as long as dialysis is a less suffi- in order to reduce transport distance. The total cost of
cient form of renal replacement therapy and younger, transport is additionally reimbursed in France, and patient
more healthy patients are removed to transplantation transportation accounts for 12 to 18% of the total cost
[14]. Our results seem to be better than those reported of HD therapy [16]. Therefore, it seems clear that social
by Okinawa, by the United States Renal Data System security could save money with H-HD and SC-HD.
report, and by Tassin [6–9], and the GMR was lower In conclusion, the out-center HD represents a reliable
in this study than in other published reports [14]. In a and safe modality of treatment for ESRD patients if an
preliminary analysis reflection, we could explain the adequate choice for the method of dialysis is done. Our
good results of the cumulative survival in our dialyzed overall survival results in out-center HD (H-HD, SC-HD)
population by the impact of patients’ selection for the appear to be excellent and were higher than in other
out-center HD (H-HD, SC-HD). This population was center structures. These better results could be related
younger and had fewer comorbid factors; essentially they in part to the bias of selection of the patients, knowing
had less association with diabetes, and represented a also that better results occur in the group at risk. Indeed,
smaller sample size than the Okinawa [8] and United
the stronger motivation of the patients and the greater
States Renal Data System [9] patients, whereas our gen-
compliance to the treatment play a role. In addition, out-eral population was comparable with the Tassin popula-
center HD ensures financial economies of the society,tion for demography and age [6]. However, the results
and these methods should be encouraged for all HDof our study seem to be better when we compared the
patients able to be treated by out-center modalities.same groups of age and the nondiabetes groups, even
with the group of 174 patients at risk [8, 9, 15], and Reprint requests to Dr. Walid Arkouche, Association pour l’Utilisa-
tion du Rein Artificiel a` Lyon, Les Tilleuls, 52 Boulevard Pinel, 69003despite the higher rate of transplantation in A.U.R.A.L.
Lyon, France.patients than in the group from Okinawa, arguing for
the beneficial effect of the out-center treatment on the
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